Return to homepagePandemic Pact

Convalescent Plasma for COVID-19

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA85473

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $256,408.14

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    Monash University

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Clinical trials for disease management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This study will evaluate whether administration of plasma containing antibodies against COVID-19, collected from people who have recovered from the infection, is safe and improves outcomes for patients admitted to hospital or intensive care with COVID-19. In partnership with Australian Red Cross Lifeblood, we will establish the process to collect, test and administer the convalescent plasma. We will then test whether it is safe and effective in two large, multicentre, national clinical trials.